Microglia, a population of central nervous system (CNS) macrophages, h
ave been demonstrated to support immune accessory and effector functio
ns in the CNS. Numerous studies support the role of microglia in CNS d
evelopment and pathology, where activation of microglia is consistentl
y noted. The current study investigated microglial immune functions un
der basal and activation conditions and assessed the ability of interl
eukin-10 (IL-10), added exogenously or produced by microglia, to down-
regulate microglial functions. This report demonstrates that microglia
from the adult human brain produce IL-10 following interferon-gamma/l
ipopolysaccharide activation. Functionally, recombinant human IL-10 do
wn-regulated basal HLA-DR expression by microglia and inhibited, in a
dose-dependent response, the ability of microglia to stimulate CD4(+)
T-cells in antigen presentation assays. These data, together with rece
nt observations of the inhibition of experimental allergic encephalomy
elitis (EAE) following IL-10 administration and reduced CNS infection
by Listeria monocytogenes after anti-IL-10 treatment, suggest that IL-
10 production by microglia may have important immune-regulatory functi
ons in CNS disease and disease models. Copyright (C) 1996 Elsevier Sci
ence Ltd.